THC240719P115000
- 0.22
- 0.000.00%
Tenet Healthcare Newsroom
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Some Confidence Is Lacking In Tenet Healthcare Corporation's (NYSE:THC) P/S
It's not a stretch to say that Tenet Healthcare Corporation's (NYSE:THC) price-to-sales (or "P/S") ratio of 0.6x right now seems quite "middle-of-the-road" for companies in the Healthcare industry
Tenet Healthcare Is Maintained at Overweight by Barclays
Tenet Healthcare Is Maintained at Overweight by
Tenet Healthcare Price Target Raised to $156.00/Share From $147.00 by Barclays
Tenet Healthcare Price Target Raised to $156.00/Share From $147.00 by
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $156
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $147 to $156.
$1000 Invested In This Stock 15 Years Ago Would Be Worth $10,000 Today
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 3.74% on an annualized basis producing an average annual return of 16.47%. Currently, Tenet Healthcare has a market
Tenet Healthcare (THC) Is a Top-Ranked Value Stock: Should You Buy?
Express News | Tenet Healthcare Inc. : Barclays Raises Target Price to $156 From $147
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $156
Barclays analyst Andrew Mok CFA maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $147 to $156.According to TipRanks data, the analyst has a success rate of 44.
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Tenet Healthcare Price Target Maintained With a $112.00/Share by Cantor Fitzgerald
Tenet Healthcare Price Target Maintained With a $112.00/Share by Cantor
Zacks.com Featured Highlights Include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
Tenet Healthcare Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
In the last three months, 13 analysts have published ratings on Tenet Healthcare (NYSE:THC), offering a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of
Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $112 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Tenet Healthcare (NYSE:THC) with a Overweight and maintains $112 price target.
Express News | Tenet Healthcare Corp : Stephens Raises Target Price to $141 From $122
Shares of Healthcare Providers Are Trading Lower in Possible Reaction to Thursday's Presidential Debate.
Shares of Healthcare Providers Are Trading Lower in Possible Reaction to Thursday's Presidential Debate.
Tenet Healthcare Is Maintained at Buy by Deutsche Bank
Tenet Healthcare Is Maintained at Buy by Deutsche Bank
Tenet Healthcare Price Target Raised to $155.00/Share From $150.00 by Deutsche Bank
Tenet Healthcare Price Target Raised to $155.00/Share From $150.00 by Deutsche Bank
Tenet Healthcare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 11.66% Deutsche Bank $150 → $155 Maintains Buy 05/30/2024 0.85% JP Morgan $107 → $140 Maintains
Deutsche Numis Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $155
Deutsche Numis analyst Pito Chickering maintains $Tenet Healthcare(THC.US)$ with a buy rating, and adjusts the target price from $150 to $155.According to TipRanks data, the analyst has a success rate